000 01181 a2200337 4500
005 20250510195602.0
264 0 _c19760802
008 197608s 0 0 eng d
022 _a0011-393X
040 _aNLM
_beng
_cNLM
100 1 _aKasich, A M
245 0 0 _aLorazepam in the management of anxiety associated with chronic gastrointestinal disease: a double-blind study.
_h[electronic resource]
260 _bCurrent therapeutic research, clinical and experimental
_cMar 1976
300 _a292-306 p.
_bdigital
500 _aPublication Type: Clinical Trial; Controlled Clinical Trial; Journal Article
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAnti-Anxiety Agents
_xtherapeutic use
650 0 4 _aAnxiety
_xdrug therapy
650 0 4 _aChronic Disease
650 0 4 _aClinical Trials as Topic
650 0 4 _aFemale
650 0 4 _aGastrointestinal Diseases
_xcomplications
650 0 4 _aHumans
650 0 4 _aLorazepam
_xadverse effects
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aPlacebos
650 0 4 _aPsychiatric Status Rating Scales
773 0 _tCurrent therapeutic research, clinical and experimental
_gvol. 19
_gno. 3
_gp. 292-306
999 _c4985
_d4985